A carregar...
Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells()
Combination therapy has been regarded as a potent strategy to overcome multidrug resistance (MDR). In this study, we adopt Adjudin (ADD), a mitochondria inhibitor, and Doxorubicin (DOX), a common chemo-drug, to treat drug-resistant cancer cells (MCF-7/ADR) in combination. Given the different physico...
Na minha lista:
| Publicado no: | J Mater Chem B Mater Biol Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4865403/ https://ncbi.nlm.nih.gov/pubmed/27182439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c4tb01764a |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|